Stockscreener 앱 받기
0.5149
0.66%
0.0034
시장 영업 전:
.51
-0.0049
-0.95%
Ovid Therapeutics Inc 주식(OVID)의 최신 뉴스
Ovid Therapeutics OVID 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Ovid Therapeutics Maintains Buy Rating with $3.00 Price Target from B.Riley Financial Analyst Madison Elsaadi. - AInvest
B.Riley assumes coverage on Ovid Therapeutics stock with Buy rating - Investing.com Australia
Ovid Therapeutics Inc. Stock Analysis and ForecastMarket-crushing profits - Jammu Links News
What are analysts’ price targets for Ovid Therapeutics Inc. in the next 12 monthsUnlock powerful trading signals and alerts - Jammu Links News
Is it the right time to buy Ovid Therapeutics Inc. stockOutstanding capital growth - Jammu Links News
Does Ovid Therapeutics Inc. stock perform well during market downturnsAchieve rapid wealth accumulation with smart picks - Jammu Links News
What makes Ovid Therapeutics Inc. stock price move sharplyGet real-time alerts on high-potential stocks - Jammu Links News
Is Ovid Therapeutics Inc. stock overvalued or undervaluedTremendous financial leverage - jammulinksnews.com
Should I hold or sell Ovid Therapeutics Inc. stock in 2025Invest smarter with actionable stock recommendations - Jammu Links News
What institutional investors are buying Ovid Therapeutics Inc. stockBuild a balanced portfolio for long-term success - Jammu Links News
How strong is Ovid Therapeutics Inc. company’s balance sheetMaximize gains with strategic stock entries - Jammu Links News
How does Ovid Therapeutics Inc. compare to its industry peersFree Wealth Planning Blueprint - Jammu Links News
Why is Ovid Therapeutics Inc. stock attracting strong analyst attentionSuperior stock growth - Jammu Links News
What is the dividend policy of Ovid Therapeutics Inc. stockUnrivaled growth potential - Jammu Links News
What are the technical indicators suggesting about Ovid Therapeutics Inc.Take advantage of unprecedented market momentum - Jammu Links News
Will Ovid Therapeutics Inc. price bounce be sustainableFree Fast Gaining Stock Screener Report - Newser
Is Ovid Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Short interest data insights for Ovid Therapeutics Inc.Summary of Reliable Long-Term Trade Models - Newser
What technical models suggest about Ovid Therapeutics Inc.’s comebackHigh Accuracy Trade Setup Identification - Newser
Ovid Therapeutics Inc (OVID) Stock: A Year of Market Movement, Down and Up - investchronicle.com
Is Ovid Therapeutics Inc. stock poised for growthTrade Setup Builder with Custom Alerts - Newser
Multi asset correlation models including Ovid Therapeutics Inc.Free Secure Capital Picks With Upside Potential - Newser
Combining price and volume data for Ovid Therapeutics Inc.Buy Strategy with Smart Exit Timing - Newser
Identifying reversal signals in Ovid Therapeutics Inc.Low Volatility Stock Analysis With Confidence - Newser
Why Ovid Therapeutics Inc. stock attracts strong analyst attentionBear Market Safe Zone Technical Analysis - Newser
Quantitative breakdown of Ovid Therapeutics Inc. recent moveDaily Exit and Entry Price Prediction - Newser
Ovid Therapeutics Inc. Stock Support and Resistance Levels You Should KnowWeekly Gain Forecast with Momentum Indicators - Newser
Published on: 2025-07-30 02:43:14 - beatles.ru
Institutional Tools Highlight Unusual Flow in Ovid Therapeutics Inc.Breakout Momentum Picks With Protection Outlined - metal.it
Analyzing Ovid Therapeutics Inc. with multi timeframe chartsConsistent Profit Signals with AI Models - Newser
Published on: 2025-07-29 00:10:51 - metal.it
Published on: 2025-07-28 19:38:56 - metal.it
Has Ovid Therapeutics Inc. formed a bullish divergenceEarnings Play Trade Plan With Alerts Shared - metal.it
Ovid Therapeutics Inc (OVID) Stock: A Comprehensive 52-Week Review - investchronicle.com
Using R and stats models for Ovid Therapeutics Inc. forecastingBuy and Hold Return Summary with Charts - Newser
How Ovid Therapeutics Inc. stock performs during market volatilityEarnings Impact and Stock Reaction Analysis - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):